Rudolf Meixner

Rudolf Meixner serves as CEO at Plasmavita Healthcare GmbH. Plasmavita Healthcare GmbH operates in the pharmaceuticals sector with approximately 33.0 employees. The company is headquartered in Vienna, Vienna.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 395 executive contacts are available in Vienna.
• • Our database includes 201,468 c suite-level executives.

Microsoft Office 365 WordPress.org Google Play Mobile Friendly Facebook Custom Audiences Google Tag Manager Facebook Widget Apache Facebook Login (Connect)

pharmaceutical manufacturing plasma donation healthcare human plasma blood plasma plasma donation centers plasma processing patient care immune globulin plasma proteins blood components plasma collection medical professionals plasma apheresis health check life-saving medication blood group compatibility blood coagulation medical supply plasma-based therapies rehydration medical research donor compensation medical treatment patient safety health guidelines center locations appointment reservation patient information medical examination donor eligibility blood donation clinical trials health insurance biomedical regulatory compliance emergency care chronic illnesses medical conditions quality assurance staff training personal data protection data privacy community engagement patient support donor community nurse & technician medical equipment maintenance pharmaceuticals medical health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Rudolf Meixner in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Plasmavita Healthcare GmbH.

Rudolf Meixner's Position in the MessageCEO Database

• •Rudolf Meixner is 1 of 1 verified executive contact we track at Plasmavita Healthcare GmbH.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •394 verified executive contacts in Vienna are in the database.
• •13 verified contacts work at pharmaceuticals companies in the 33.0 employee range (same size as Plasmavita Healthcare GmbH).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Rudolf Meixner directly?

Rudolf Meixner's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Plasmavita Healthcare GmbH. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rudolf Meixner work for?

Rudolf Meixner is CEO at Plasmavita Healthcare GmbH, a company in the pharmaceuticals sector with 33.0 employees. The company is based in Vienna, Vienna.

Can I pitch or sell to Rudolf Meixner?

As CEO at Plasmavita Healthcare GmbH, Rudolf Meixner is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Rudolf Meixner directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rudolf Meixner in?

Rudolf Meixner works in the pharmaceuticals industry as CEO at Plasmavita Healthcare GmbH. MessageCEO provides verified contact information for executives across all major industries.

Is Rudolf Meixner's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rudolf Meixner's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026